Berardinelli-Seip congenital lipodystrophy 2 regulates adipocyte lipolysis, browning, and energy balance in adult animals

Journal of Lipid Research

Volumn 56, Issue 10, 2015, Pages 1912-1925

  Zhou, Hongyi ^a   Lei, Xinnuo ^a   Benson, Tyler ^a   Mintz, James ^a   Xu, Xiaojing ^a   Harris, Ruth B ^a   Weintraub, Neal L ^a   Wang, Xiaoling ^a   Chen, Weiqin ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Adipose tissue; Beta oxidation; Lipolysis and fatty acid metabolism; Obesity; Triglycerides

Indexed keywords

G PROTEIN COUPLED RECEPTOR; INSULIN; MEMBRANE PROTEIN; PROTEIN BSCL2; UNCLASSIFIED DRUG; BETA 3 ADRENERGIC RECEPTOR; BSCL2 PROTEIN, MOUSE; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; TRIACYLGLYCEROL;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BROWN ADIPOSE TISSUE; CONGENITAL GENERALIZED LIPODYSTROPHY; CONGENITAL GENERALIZED LIPODYSTROPHY TYPE 2; CONTROLLED STUDY; ENERGY BALANCE; ENERGY EXPENDITURE; ENVIRONMENTAL TEMPERATURE; EX VIVO STUDY; FATTY ACID OXIDATION; GENE EXPRESSION PROFILING; GLYCATION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID DIET; LIPOLYSIS; MALE; MOUSE; NONHUMAN; OBESITY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; THERMOGENESIS; ANIMAL; C57BL MOUSE; DISEASE MODEL; ENERGY METABOLISM; FATTY LIVER; GENETICS; KNOCKOUT MOUSE; LIPID METABOLISM; METABOLISM; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ANIMALS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; FATTY LIVER; HETEROTRIMERIC GTP-BINDING PROTEINS; INSULIN RESISTANCE; LIPID METABOLISM; LIPODYSTROPHY, CONGENITAL GENERALIZED; LIPOLYSIS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, ADRENERGIC, BETA-3; TRIGLYCERIDES;

EID: 84946558071     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M060244     Document Type: Article

References (72)

1. Agarwal, A. K., R. I. Barnes, and A. Garg. 2004. Genetic basis of con-genital generalized lipodystrophy. Int. J. Obes. Relat. Metab. Disord. 28: 336-339.
2. Berardinelli, W. 1954. An undiagnosed endocrinometabolic syn-drome: report of 2 cases. J. Clin. Endocrinol. Metab. 14: 193-204.
3. Seip, M., and O. Trygstad. 1996. Generalized lipodystrophy, con-genital and acquired (lipoatrophy). Acta Paediatr. Suppl. 413: 2-28.
4. Garg, A., R. Wilson, R. Barnes, E. Arioglu, Z. Zaidi, F. Gurakan, N. Kocak, S. O'Rahilly, S. I. Taylor, S. B. Patel, et al. 1999. A gene for congenital generalized lipodystrophy maps to human chromosome 9q34. J. Clin. Endocrinol. Metab. 84: 3390-3394.
5. Hayashi, Y. K., C. Matsuda, M. Ogawa, K. Goto, K. Tominaga, S. Mitsuhashi, Y. E. Park, I. Nonaka, N. Hino-Fukuyo, K. Haginoya, et al. 2009. Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodys-trophy. J. Clin. Invest. 119: 2623-2633.
6. Kim, C. A., M. Delepine, E. Boutet, H. El Mourabit, S. Le Lay, M. Meier, M. Nemani, E. Bridel, C. C. Leite, D. R. Bertola, et al. 2008. Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy. J. Clin. Endocrinol. Metab. 93: 1129-1134.
7. Magré, J., M. Delépine, E. Khallouf, T. Gedde-Dahl, Jr., L. Van Maldergem, E. Sobel, J. Papp, M. Meier, A. Mégarbané, A. Bachy, et al. 2001. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat. Genet. 28: 365-370.
8. Agarwal, A. K., and A. Garg. 2003. Congenital generalized lipodys-trophy: significance of triglyceride biosynthetic pathways. Trends Endocrinol. Metab. 14: 214-221.
9. Chen, W., V. K. Yechoor, B. H. Chang, M. V. Li, K. L. March, and L. Chan. 2009. The human lipodystrophy gene product Berardinelli-Seip congenital lipodystrophy 2/seipin plays a key role in adipocyte differentiation. Endocrinology. 150: 4552-4561.
10. Chen, W., B. Chang, P. Saha, S. M. Hartig, L. Li, V. T. Reddy, Y. Yang, V. Yechoor, M. A. Mancini, and L. Chan. 2012. Berardinelli-Seip congenital lipodystrophy 2/seipin is a cell-autonomous regulator of lipolysis essential for adipocyte differentiation. Mol. Cell. Biol. 32: 1099-1111.
11. Cui, X., Y. Wang, Y. Tang, Y. Liu, L. Zhao, J. Deng, G. Xu, X. Peng, S. Ju, G. Liu, et al. 2011. Seipin ablation in mice results in severe generalized lipodystrophy. Hum. Mol. Genet. 20: 3022-3030.
12. Prieur, X., L. Dollet, M. Takahashi, M. Nemani, B. Pillot, C. Le May, C. Mounier, H. Takigawa-Imamura, D. Zelenika, F. Matsuda, et al. 2013. Thiazolidinediones partially reverse the metabolic disturbances observed in Bscl2/seipin-deficient mice. Diabetologia. 56: 1813-1825.
13. Ebihara, C., K. Ebihara, M. Aizawa-Abe, T. Mashimo, T. Tomita, M. Zhao, V. Gumbilai, T. Kusakabe, Y. Yamamoto, D. Aotani, et al. 2015. Seipin is necessary for normal brain development and spermatogenesis in addition to adipogenesis. Hum. Mol. Genet. 24: 4238-4249.
14. Fei, W., G. Shui, B. Gaeta, X. Du, L. Kuerschner, P. Li, A. J. Brown, M. R. Wenk, R. G. Parton, and H. Yang. 2008. Fld1p, a functional homologue of human seipin, regulates the size of lipid droplets in yeast. J. Cell Biol. 180: 473-482.
15. Szymanski, K. M., D. Binns, R. Bartz, N. V. Grishin, W. P. Li, A. K. Agarwal, A. Garg, R. G. Anderson, and J. M. Goodman. 2007. The lipodystrophy protein seipin is found at endoplasmic reticulum lipid droplet junctions and is important for droplet morphology. Proc. Natl. Acad. Sci. USA. 104: 20890-20895.
16. Fei, W., G. Shui, Y. Zhang, N. Krahmer, C. Ferguson, T. S. Kapterian, R. C. Lin, I. W. Dawes, A. J. Brown, P. Li, et al. 2011. A role for phos-phatidic acid in the formation of "supersized" lipid droplets. PLoS Genet. 7: e1002201.
17. Wolinski, H., D. Kolb, S. Hermann, R. I. Koning, and S. D. Kohlwein. 2011. A role for seipin in lipid droplet dynamics and inheritance in yeast. J. Cell Sci. 124: 3894-3904.
18. 2+-ATPase SERCA. Cell Metab. 19: 861-871.
19. Liu, L., Q. Jiang, X. Wang, Y. Zhang, R. C. Lin, S. M. Lam, G. Shui, L. Zhou, P. Li, Y. Wang, et al. 2014. Adipose-specific knockout of SEIPIN/BSCL2 results in progressive lipodystrophy. Diabetes. 63: 2320-2331.
20. Sim, M. F., R. J. Dennis, E. M. Aubry, N. Ramanathan, H. Sembongi, V. Saudek, D. Ito, S. O'Rahilly, S. Siniossoglou, and J. J. Rochford. 2012. The human lipodystrophy protein seipin is an ER membrane adaptor for the adipogenic PA phosphatase lipin 1. Mol. Metab. 2: 38-46.
21. Talukder, M. M., M. F. Sim, S. O'Rahilly, J. M. Edwardson, and J. J. Rochford. 2015. Seipin oligomers can interact directly with AGPAT2 and lipin 1, physically scaffolding critical regulators of adipogenesis. Mol. Metab. 4: 199-209.
22. Harms, M., and P. Seale. 2013. Brown and beige fat: development, function and therapeutic potential. Nat. Med. 19: 1252-1263.
23. Langin, D. 2010. Recruitment of brown fat and conversion of white into brown adipocytes: strategies to fight the metabolic complications of obesity? Biochim. Biophys. Acta. 1801: 372-376.
24. Bartelt, A., and J. Heeren. 2012. The holy grail of metabolic dis-ease: brown adipose tissue. Curr. Opin. Lipidol. 23: 190-195.
25. Giacobino, J. P. 1995. Beta 3-adrenoceptor: an update. Eur. J. Endocrinol. 132: 377-385.
26. Bachman, E. S., H. Dhillon, C. Y. Zhang, S. Cinti, A. C. Bianco, B. K. Kobilka, and B. B. Lowell. 2002. betaAR signaling required for diet-induced thermogenesis and obesity resistance. Science. 297: 843-845.
27. Grujic, D., V. S. Susulic, M. E. Harper, J. Himms-Hagen, B. A. Cunningham, B. E. Corkey, and B. B. Lowell. 1997. Beta3-adrenergic receptors on white and brown adipocytes mediate beta3-selective agonist-induced effects on energy expenditure, insulin secretion, and food intake. A study using transgenic and gene knockout mice. J. Biol. Chem. 272: 17686-17693.
28. Hu, B., and L. L. Jennings. 2003. Orally bioavailable beta 3-adrenergic receptor agonists as potential therapeutic agents for obesity and type-II diabetes. Prog. Med. Chem. 41: 167-194.
29. Weyer, C., P. A. Tataranni, S. Snitker, E. Danforth, Jr., and E. Ravussin. 1998. Increase in insulin action and fat oxidation after treatment with CL 316, 243, a highly selective beta3-adrenoceptor agonist in humans. Diabetes. 47: 1555-1561.
30. Cannon, B., and J. Nedergaard. 2004. Brown adipose tissue: func-tion and physiological significance. Physiol. Rev. 84: 277-359.
31. Sassmann, A., S. Offermanns, and N. Wettschureck. 2010. Tamoxifen-inducible Cre-mediated recombination in adipocytes. Genesis. 48: 618-625.
32. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
33. Samuel, V. T., Z. X. Liu, X. Qu, B. D. Elder, S. Bilz, D. Befroy, A. J. Romanelli, and G. I. Shulman. 2004. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J. Biol. Chem. 279: 32345-32353.
34. Xue, Y., N. Petrovic, R. Cao, O. Larsson, S. Lim, S. Chen, H. M. Feldmann, Z. Liang, Z. Zhu, J. Nedergaard, et al. 2009. Hypoxia-independent angiogenesis in adipose tissues during cold acclimation. Cell Metab. 9: 99-109.
35. Liew, C. W., J. Boucher, J. K. Cheong, C. Vernochet, H. J. Koh, C. Mallol, K. Townsend, D. Langin, D. Kawamori, J. Hu, et al. 2013. Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance. Nat. Med. 19: 217-226.
36. Kim, K. H., Y. T. Jeong, H. Oh, S. H. Kim, J. M. Cho, Y. N. Kim, S. S. Kim, H. Kim do, K. Y. Hur, H. K. Kim, et al. 2013. Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine. Nat. Med. 19: 83-92.
37. Hirschey, M. D., T. Shimazu, E. Goetzman, E. Jing, B. Schwer, D. B. Lombard, C. A. Grueter, C. Harris, S. Biddinger, O. R. Ilkayeva, et al. 2010. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature. 464: 121-125.
38. Chang, B. H., L. Li, A. Paul, S. Taniguchi, V. Nannegari, W. C. Heird, and L. Chan. 2006. Protection against fatty liver but normal adipogenesis in mice lacking adipose differentiation-related protein. Mol. Cell. Biol. 26: 1063-1076.
39. Mori, M. A., T. Thomou, J. Boucher, K. Y. Lee, S. Lallukka, J. K. Kim, M. Torriani, H. Yki-Jarvinen, S. K. Grinspoon, A. M. Cypess, et al. 2014. Altered miRNA processing disrupts brown/white adipo-cyte determination and associates with lipodystrophy. J. Clin. Invest. 124: 3339-3351.
40. Cortés, V. A., D. E. Curtis, S. Sukumaran, X. Shao, V. Parameswara, S. Rashid, A. R. Smith, J. Ren, V. Esser, R. E. Hammer, et al. 2009. Molecular mechanisms of hepatic steatosis and insulin resistance in the AGPAT2-deficient mouse model of congenital generalized lipodystrophy. Cell Metab. 9: 165-176.
41. Subauste, A. R., A. K. Das, X. Li, B. G. Elliott, C. Evans, M. El Azzouny, M. Treutelaar, E. Oral, T. Leff, and C. F. Burant. 2012. Alterations in lipid signaling underlie lipodystrophy secondary to AGPAT2 mutations. Diabetes. 61: 2922-2931.
42. Sul, H. S. 2009. Pref-1: Role in adipogenesis and mesenchymal cell fate. Mol. Endocrinol. 23: 1717-1725.
43. Dalen, K. T., S. M. Ulven, B. M. Arntsen, K. Solaas, and H. I. Nebb. 2006. PPARalpha activators and fasting induce the expression of adipose differentiation-related protein in liver. J. Lipid Res. 47: 931-943.
44. Golozoubova, V., H. Gullberg, A. Matthias, B. Cannon, B. Vennstrom, and J. Nedergaard. 2004. Depressed thermogenesis but competent brown adipose tissue recruitment in mice devoid of all hormonebinding thyroid hormone receptors. Mol. Endocrinol. 18: 384-401.
45. Cousin, B., S. Cinti, M. Morroni, S. Raimbault, D. Ricquier, L. Penicaud, and L. Casteilla. 1992. Occurrence of brown adipocytes in rat white adipose tissue: molecular and morphological characterization. J. Cell Sci. 103: 931-942.
46. Loncar, D., B. A. Afzelius, and B. Cannon. 1988. Epididymal white adipose tissue after cold stress in rats. I. Nonmitochondrial changes. J. Ultrastruct. Mol. Struct. Res. 101: 109-122.
47. Loncar, D., L. Bedrica, J. Mayer, B. Cannon, J. Nedergaard, B. A. Afzelius, and A. Svajger. 1986. The effect of intermittent cold treatment on the adipose tissue of the cat. Apparent transformation from white to brown adipose tissue. J. Ultrastruct. Mol. Struct. Res. 97: 119-129.
48. Young, P., J. R. Arch, and M. Ashwell. 1984. Brown adipose tissue in the parametrial fat pad of the mouse. FEBS Lett. 167: 10-14.
49. Mantzoros, C. S., D. Qu, R. C. Frederich, V. S. Susulic, B. B. Lowell, E. Maratos-Flier, and J. S. Flier. 1996. Activation of beta(3) adren-ergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes. 45: 909-914.
50. Gettys, T. W., P. J. Harkness, and P. M. Watson. 1996. The beta 3-adrenergic receptor inhibits insulin-stimulated leptin secretion from isolated rat adipocytes. Endocrinology. 137: 4054-4057.
51. Puerta, M., M. Abelenda, M. Rocha, and P. Trayhurn. 2002. Effect of acute cold exposure on the expression of the adiponectin, resis-tin and leptin genes in rat white and brown adipose tissues. Horm. Metab. Res. 34: 629-634.
52. Trayhurn, P., J. S. Duncan, and D. V. Rayner. 1995. Acute cold-induced suppression of ob (obese) gene expression in white adipose tissue of mice: mediation by the sympathetic system. Biochem. J. 311: 729-733.
53. Dong, M., X. Yang, S. Lim, Z. Cao, J. Honek, H. Lu, C. Zhang, T. Seki, K. Hosaka, E. Wahlberg, et al. 2013. Cold exposure promotes atherosclerotic plaque growth and instability via UCP1-dependent lipolysis. Cell Metab. 18: 118-129.
54. Granneman, J. G., P. Li, Z. Zhu, and Y. Lu. 2005. Metabolic and cellular plasticity in white adipose tissue I: effects of beta3-adren-ergic receptor activation. Am. J. Physiol. Endocrinol. Metab. 289: E608-E616.
55. Li, P., Z. Zhu, Y. Lu, and J. G. Granneman. 2005. Metabolic and cellular plasticity in white adipose tissue II: role of peroxisome pro-liferator-activated receptor-alpha. Am. J. Physiol. Endocrinol. Metab. 289: E617-E626.
56. Mottillo, E. P., X. J. Shen, and J. G. Granneman. 2010. beta3-adrenergic receptor induction of adipocyte inflammation requires lipolytic activation of stress kinases p38 and JNK. Biochim. Biophys. Acta. 1801: 1048-1055.
57. Mottillo, E. P., A. E. Bloch, T. Leff, and J. G. Granneman. 2012. Lipolytic products activate peroxisome proliferator-activated receptor (PPAR) alpha and delta in brown adipocytes to match fatty acid oxidation with supply. J. Biol. Chem. 287: 25038-25048.
58. Chen, W., H. Zhou, S. Liu, C. J. Fhaner, B. C. Gross, T. A. Lydic, and G. E. Reid. 2013. Altered lipid metabolism in residual white adipose tissues of bscl2 deficient mice. PLoS One. 8: e82526.
59. Brasaemle, D. L., T. Barber, N. E. Wolins, G. Serrero, E. J. Blanchette-Mackie, and C. Londos. 1997. Adipose differentiation-related protein is an ubiquitously expressed lipid storage droplet-associated protein. J. Lipid Res. 38: 2249-2263.
60. Gross, D. N., H. Miyoshi, T. Hosaka, H. H. Zhang, E. C. Pino, S. Souza, M. Obin, A. S. Greenberg, and P. F. Pilch. 2006. Dynamics of lipid droplet-associated proteins during hormonally stimulated lipolysis in engineered adipocytes: stabilization and lipid droplet binding of adipocyte differentiation-related protein/adipophilin. Mol. Endocrinol. 20: 459-466.
61. Nishino, N., Y. Tamori, S. Tateya, T. Kawaguchi, T. Shibakusa, W. Mizunoya, K. Inoue, R. Kitazawa, S. Kitazawa, Y. Matsuki, et al. 2008. FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets. J. Clin. Invest. 118: 2808-2821.
62. Jaworski, K., M. Ahmadian, R. E. Duncan, E. Sarkadi-Nagy, K. A. Varady, M. K. Hellerstein, H. Y. Lee, V. T. Samuel, G. I. Shulman, K. H. Kim, et al. 2009. AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency. Nat. Med. 15: 159-168.
63. Klaus, S., P. Muzzin, J. P. Revelli, M. A. Cawthorne, J. P. Giacobino, and D. Ricquier. 1995. Control of beta 3-adrenergic receptor gene expression in brown adipocytes in culture. Mol. Cell. Endocrinol. 109: 189-195.
64. Tsai, V. W., L. Macia, H. Johnen, T. Kuffner, R. Manadhar, S. B. Jorgensen, K. K. Lee-Ng, H. P. Zhang, L. Wu, C. P. Marquis, et al. 2013. TGF-b superfamily cytokine MIC-1/GDF15 is a physiological appetite and body weight regulator. PLoS One. 8: e55174.
65. Agarwal, A. K., E. Arioglu, S. De Almeida, N. Akkoc, S. I. Taylor, A. M. Bowcock, R. I. Barnes, and A. Garg. 2002. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat. Genet. 31: 21-23.
66. Carman, G. M., and S. A. Henry. 1999. Phospholipid biosynthesis in the yeast Saccharomyces cerevisiae and interrelationship with other metabolic processes. Prog. Lipid Res. 38: 361-399.
67. Dowd, S. R., M. E. Bier, and J. L. Patton-Vogt. 2001. Turnover of phosphatidylcholine in Saccharomyces cerevisiae. The role of the CDP-choline pathway. J. Biol. Chem. 276: 3756-3763.
68. Fei, W., H. Li, G. Shui, T. S. Kapterian, C. Bielby, X. Du, A. J. Brown, P. Li, M. R. Wenk, P. Liu, et al. 2011. Molecular characterization of seipin and its mutants: implications for seipin in triacylglycerol synthesis. J. Lipid Res. 52: 2136-2147.
69. Chen, W., H. Zhou, P. Saha, L. Li, and L. Chan. 2014. Molecular mechanisms underlying fasting modulated liver insulin sensitivity and metabolism in male lipodystrophic Bscl2/Seipin-deficient mice. Endocrinology. 155: 4215-4225.
70. Chernogubova, E., B. Cannon, and T. Bengtsson. 2004. Norepi-nephrine increases glucose transport in brown adipocytes via beta3-adrenoceptors through a cAMP, PKA, and PI3-kinase-dependent pathway stimulating conventional and novel PKCs. Endocrinology. 145: 269-280.
71. Cooney, G. J., I. D. Caterson, and E. A. Newsholme. 1985. The ef-fect of insulin and noradrenaline on the uptake of 2-[1-14C]deoxy-glucose in vivo by brown adipose tissue and other glucose-utilising tissues of the mouse. FEBS Lett. 188: 257-261.
72. Liu, X., F. Perusse, and L. J. Bukowiecki. 1994. Chronic norepi-nephrine infusion stimulates glucose uptake in white and brown adipose tissues. Am. J. Physiol. 266: R914-R920.